New Report on Grantmaking During COVID-19

In this report preview, discover how more than 100 funders overcame the difficulties of 2020 and are preparing for the future.

News & Updates

The Community Survey: Benefits and Best Practices for Small Businesses during COVID-19

A community survey is a great tool for small businesses looking to gain insight and respond succesfully, during COVID-19 and beyond.

News & Updates

COVID 19 Response: Artist Trust Moves Fast to Fund Washington Artists

Artist Trust launched one of the first COVID-19 emergency relief funds for artists using Submittable, through which they’ve awarded $475K to date.

News & Updates

COVID-19 Response: Crew Nation Commits $10 Million to Live Music Crews

Crew Nation has launched a global relief fund through Submittable, with $10 million committed to supporting live music crews during COVID-19.

News & Updates

COVID-19 Response: Bread & Roses Will Award $500K for Grassroots Organizing

Bread & Roses is operating its Solidarity Fund for COVID-19 Organizing through Submittable, with a plan to provide $500,000 in emergency grants. 

News & Updates

COVID-19 Response: Arts Mid-Hudson Measures Grantee and Awardee Impact

Arts Mid-Hudson is contintuing to serve artists during COVID-19 by assessing community impact using a Submittable survey form.

News & Updates

COVID-19 Response: Women in Cloud Addresses Impact Among Female Tech Entrepreneurs

Women in Cloud is using Submittable to collect impact data regarding COVID-19 from female tech entrepreneurs to support recovery.

News & Updates

COVID-19 Response: Fund for Investigative Journalism Supports Longform Journalists

Using Submittable, the Fund for Investigative Journalism has launched emergency grants of up to $10,000 for freelancers in response to COVID-19.

News & Updates

COVID-19 Response: AIR’s Freelance Audio Fund Supports Professionals and Assesses Impact

AIR’s Freelance Audio Fund, launched through Submittable, is providing emergency relief for the professional audio community during COVID-19.